1. Home
  2. DYAI vs NMTC Comparison

DYAI vs NMTC Comparison

Compare DYAI & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYAI
  • NMTC
  • Stock Information
  • Founded
  • DYAI 1979
  • NMTC 2009
  • Country
  • DYAI United States
  • NMTC United States
  • Employees
  • DYAI N/A
  • NMTC N/A
  • Industry
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • NMTC Medical/Dental Instruments
  • Sector
  • DYAI Health Care
  • NMTC Health Care
  • Exchange
  • DYAI Nasdaq
  • NMTC Nasdaq
  • Market Cap
  • DYAI 31.3M
  • NMTC 30.9M
  • IPO Year
  • DYAI 2004
  • NMTC N/A
  • Fundamental
  • Price
  • DYAI $0.97
  • NMTC $0.59
  • Analyst Decision
  • DYAI Strong Buy
  • NMTC Strong Buy
  • Analyst Count
  • DYAI 1
  • NMTC 1
  • Target Price
  • DYAI $6.00
  • NMTC $1.45
  • AVG Volume (30 Days)
  • DYAI 37.8K
  • NMTC 273.1K
  • Earning Date
  • DYAI 05-14-2025
  • NMTC 05-13-2025
  • Dividend Yield
  • DYAI N/A
  • NMTC N/A
  • EPS Growth
  • DYAI N/A
  • NMTC N/A
  • EPS
  • DYAI N/A
  • NMTC N/A
  • Revenue
  • DYAI $3,554,344.00
  • NMTC $5,758,777.00
  • Revenue This Year
  • DYAI $22.56
  • NMTC $141.04
  • Revenue Next Year
  • DYAI $30.95
  • NMTC $38.86
  • P/E Ratio
  • DYAI N/A
  • NMTC N/A
  • Revenue Growth
  • DYAI 57.59
  • NMTC 54.53
  • 52 Week Low
  • DYAI $0.93
  • NMTC $0.40
  • 52 Week High
  • DYAI $2.67
  • NMTC $1.39
  • Technical
  • Relative Strength Index (RSI)
  • DYAI 36.18
  • NMTC 43.47
  • Support Level
  • DYAI $0.95
  • NMTC $0.55
  • Resistance Level
  • DYAI $1.13
  • NMTC $0.62
  • Average True Range (ATR)
  • DYAI 0.08
  • NMTC 0.05
  • MACD
  • DYAI 0.00
  • NMTC -0.00
  • Stochastic Oscillator
  • DYAI 20.00
  • NMTC 30.00

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.

Share on Social Networks: